跳至主要内容
临床试验/IRCT2014110519816N1
IRCT2014110519816N1已完成2 期

The effects of pro-biotic on inflammation factors in patients with type 2 diabetes mellitus

Sabzevar University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 60 years(—)
性别
All

入选标准

  • patients affected to diabetes melitus type 2; body mass index <35 kg/m2; patients enrolled in this study should have no infectious disease, hepatitis or renal diseases.
  • Exclusion criteria: patients received cholesterol-lowering drugs, probiotic, prebiotic and omega-3 fatty acids and antibiotics from 1 month before and during the study.

排除标准

  • 未提供

研究者

发起方
Sabzevar University of Medical Sciences

相似试验

Pro-biotic on inflammation factors in patients with... | 临床试验